SCHEMBL23010409

SCHEMBL23010409

COC(=O)c1cc(C(=O)C(C)=O)n(C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.46
CYP2C19 P33261 3/20 0.46
PKM P14618 2/20 0.45
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA7 P43166 3/20 0.40
CA9 Q16790 3/20 0.40
CA14 Q9ULX7 3/20 0.40
KDM4E B2RXH2 5/20 0.39
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
XDH P47989 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
GFER P55789 1/20 0.39
FUT7 Q11130 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21408377 0.86 CYP1A2 (0.46) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL9713997 0.85 CYP1A2 (0.57) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL21408469 0.80 ALDH1A1 (0.48) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL21408358 0.80 CYP1A2 (0.41) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL11063029 0.79 CYP1A2 (0.55) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL16416490 0.76 CYP1A2 (0.52) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL10940181 0.76 TSHR (0.55) CYP1A2CYP2C19PKMKDM4EPOLB
SCHEMBL21570127 0.75 CYP1A2 (0.55) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL17838295 0.75 CYP1A2 (0.55) CYP1A2CYP2C19PKMCA12CA1
SCHEMBL10937884 0.74 TDP1 (0.56) CYP1A2CYP2C19PKMCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778569-A1 N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2021-02-17 EP disclosed